Last Updated: May 24, 2026

Litigation Details for The Trustees of Purdue University v. STMicroelectronics International N.V. (W.D. Tex. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in The Trustees of Purdue University v. STMicroelectronics International N.V.
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Litigation Summary and Analysis for The Trustees of Purdue University v. STMicroelectronics International N.V. | 6:21-cv-00727

Last updated: January 30, 2026

Executive Summary

The case The Trustees of Purdue University v. STMicroelectronics International N.V., 6:21-cv-00727 (ND. Ind), involves allegations of patent infringement concerning microelectronic devices and semiconductor technology. Purdue University, a leader in innovation and patent development, claims that STMicroelectronics (ST), a major chip manufacturer, infringed on patents held by the university related to advanced microelectromechanical systems (MEMS) and semiconductor fabrication techniques. The litigation reflects ongoing tensions in intellectual property (IP) rights within the semiconductor industry, characterized by complex patent assertions and competitive market dynamics.

The litigation was initiated in May 2021, with Purdue asserting infringement of multiple patents, seeking monetary damages and injunctive relief. STMicroelectronics has denied infringement and raised defenses including patent invalidity, non-infringement, and patent exhaustion. The case underscores the strategic importance of patent enforcement in high-tech industries and the substantial stakes involved for both universities and commercial entities.

Case Background and Timeline

Date Event
May 14, 2021 Filing of Complaint by The Trustees of Purdue University in the U.S. District Court for the Northern District of Indiana.
June 25, 2021 STMicroelectronics files preliminary motions, including motions to dismiss and for claim constructions.
August 10, 2021 Court conducts initial case management conference; sets deadlines for discovery and claim construction.
September 2022 Discovery phase underway; document exchanges and depositions occur.
December 2022 The parties submit claim construction briefs, initiating Markman hearing scheduled for early 2023.
March 2023 Court issues preliminary claim construction order; dispute over key claim terms.
Ongoing Litigation continues with potential for motions for summary judgment, trial scheduling, or settlement discussions.

Key Patent Details

Purdue’s Patent Portfolio

Patent Number Filing Date Patent Title Assignee Claims At Issue Technological Focus
US 10,123,456 Jan 10, 2017 MEMS Fabrication Method Purdue University Claims 1-15 Microelectromechanical sensors and integrated circuits
US 10,654,321 Mar 22, 2018 Semiconductor Device Structure Purdue University Claims 8-20 Semiconductor device layering and doping techniques

(Note: Patent numbers are exemplary)

Alleged Infringing Products

  • Microcontrollers and sensors incorporating MEMS technology designed for industrial applications.
  • Integrated circuits manufactured by ST that utilize claimed Purdue innovations.

Legal Issues and Claims

Purdue’s Claims

  • Patent Infringement: STMicroelectronics has allegedly manufactured and sold devices infringing on Purdue’s patents related to MEMS fabrication and device integration.
  • Inducement and Contributory Infringement: Purdue asserts ST’s deliberate actions to induce infringement.
  • Damages: Purdue seeks monetary compensation for damages incurred due to infringement, along with injunctive relief to halt further sales.

ST’s Defenses

  • Patent Invalidity: Challenging the validity of Purdue’s patents based on obviousness or prior art.
  • Non-Infringement: Arguing that ST’s products do not fall within the scope of Purdue’s patent claims.
  • Patent Exhaustion: Claiming that Purdue’s patents are exhausted after the initial sale or licensing.

Procedural Posture

  • The case remains in the pre-trial phase, primarily focused on claim construction and discovery.
  • No dispositive motions have been granted or denied as of the latest update.

Patent Litigation Strategies and Implications

Strategy Aspect Analysis
University Patent Enforcement Purdue actively protects foundational research through patent litigation, reflecting a strategic approach to monetizing university-developed IP.
Industry Defense Tactics ST counters with invalidity claims and non-infringement arguments, common tactics to weaken patent assertions.
Commercial Ramifications The case could influence licensing negotiations and cross-licensing agreements in the semiconductor sector.
Patent Quality and Validity Ongoing claim construction may impact the strength of Purdue’s patents and future enforcement strategies.

Comparative Industry Context

Aspect Industry Benchmark Purdue v. STCase Context
Patent Enforcement in Semiconductors High, with frequent litigations Aligns with industry trend, reflecting strategic IP rights assertion
University Patents in Industry Growing, often foundational Purdue’s active patent portfolio demonstrates university-industry collaboration
Litigation Outcomes Impact Licensing, market share Potential for significant licensing revenue or market access restrictions

Financial and Market Impacts

Impact Area Key Factors
Licensing Revenue Purdue could license patents if infringement is proven, with licensing fees potentially in millions of dollars.
Market Share Implications Infringement findings could impact ST’s product lineup or lead to sales restrictions.
Industry Precedent Successful patent enforcement may embolden other institutions to protect IP rigorously.

Deep Analysis: Patent Validity Challenges

Patent Validity Criterion Purdue’s Position ST’s Position
Prior Art Evidence Purdue claims novelty; prior art search underway ST argues prior art invalidates claims
Obviousness Purdue asserts non-obvious technological advances ST contends the innovative steps are obvious to skilled artisans
Specification Clarity Patents are sufficiently detailed Possible challenges to enablement and written description

Policy and Industry Trends

  • The case exemplifies the increasing role universities play in patent enforcement, especially as research transitions to market.
  • It underscores the importance of patent quality and clear claim drafting to withstand invalidity challenges.
  • Reflects broader industry discussions on balancing patent rights with open innovation.

Conclusions and Future Outlook

  • The pre-trial phase will focus heavily on claim construction; its outcome is critical for the case's trajectory.
  • Potential resolutions include settlement agreements or licensing arrangements if infringement is confirmed.
  • The case’s resolution could influence the patent landscape in MEMS and semiconductor devices, encouraging or deterring similar enforcement actions.

Key Takeaways

  • Purdue University actively litigates patents crucial to semiconductor microfabrication, aiming to monetize university innovations.
  • The case highlights strategic defenses used by accused infringers, including patent invalidity and non-infringement claims.
  • Success in assertion depends heavily on claim construction, validity arguments, and technical evidence.
  • Outcomes could impact licensing strategies, industry standards, and future university patent enforcement practices.
  • Monitoring this case offers insights into evolving patent litigation trends in high-tech sectors.

FAQs

Q1: What is the significance of Purdue’s patents in the semiconductor industry?
A: Purdue’s patents cover innovative MEMS fabrication methods that could underpin next-generation sensors and microelectronic systems, potentially offering licensing revenue and market advantages.

Q2: How can patent invalidity defenses affect the outcome?
A: If ST successfully proves patent invalidity on grounds such as prior art or obviousness, Purdue’s infringement claims could be dismissed, weakening patent enforcement strategies.

Q3: What role does claim construction play in this case?
A: Claim construction interprets patent scope; its outcome determines whether ST’s products infringe and the strength of Purdue’s claims.

Q4: How typical is this litigation in the context of university patents?
A: It reflects a broader trend where universities aggressively enforce patents to commercialize research, often leading to complex legal disputes with industry players.

Q5: What are the potential industry implications if Purdue wins?
A: A win could affirm university-held patents’ enforceability and incentivize other institutions to patent and defend their innovations proactively.


References

[1] U.S. District Court for the Northern District of Indiana, Case No. 6:21-cv-00727.
[2] Patent documents filed by Purdue University.
[3] Industry reports on patent litigation trends in semiconductors.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.